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Abstract
Low molecular weight heparins are complex polycomponent drugs that have recently
become amenable to top-down analysis using liquid chromatography-mass spectrometry.
Even using open source deconvolution software, DeconTools, and automatic structural
assignment software, GlycReSoft, the comparison of two or more low molecular weight hep-
arins is extremely time-consuming, taking about a week for an expert analyst and provides
no guarantee of accuracy. Efficient data processing tools are required to improve analysis.
This study uses the programming language of Microsoft Excel™ Visual Basic for Applica-
tions to extend its standard functionality for macro functions and specific mathematical mod-
ules for mass spectrometric data processing. The program developed enables the
comparison of top-down analytical glycomics data on two or more low molecular weight hep-
arins. The current study describes a new program, GlycCompSoft, which has a low error
rate with good time efficiency in the automatic processing of large data sets. The experimen-
tal results based on three lots of Lovenox®, Clexane® and three generic enoxaparin samples
show that the run time of GlycCompSoft decreases from 11 to 2 seconds when the data pro-
cessed decreases from 18000 to 1500 rows.
Introduction
Heparin is a complex, polydisperse and structurally heterogeneous mixture of linear, anionic
polysaccharides that is widely used as a clinical anticoagulant [1]. Discovered 100 years ago in
1916, heparin’s use predated the establishment of the U.S. Food and Drug Administration
(FDA) [1]. Low molecular weight (LMW) heparins, introduced in the 1990s for their improved
pharmacodynamics and bioavailability, are derived from heparin by controlled depolymeriza-
tion. LMW heparins, including innovator drugs and more recently generic versions, have
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undergone a great deal of regulatory scrutiny because of their polycomponent nature and their
high level of structural complexity [2]. Studies of new approaches to determine the structure of
LMW heparins have included bottom-up [3], top-down [4] and combined liquid chromatog-
raphy (LC)-mass spectrometry (MS) analysis [5–6]. Despite these major advances, the rapid
and accurate glycomic analysis of glycosaminoglycans by LC-MS has been plagued by the
absence of suitable bioinformatics software.
In contrast to glycomic analysis, proteomic analysis using LC-MS is highly developed [7–8].
The availability of bioinformatics software has made routine proteomic analysis available to
non-experts and has allowed expert laboratories to take on more difficult challenges, such as
prost-translational modifications [9]. Recently, there has been an increased interest in develop-
ing similar bioinformatics software for glycomic analysis [10–11]. In the area of glycosamino-
glycan analysis, GlycReSoft 1.0 software, developed at Boston University by Zaia and
coworkers [12], relies on raw mass spectral data after auto-processed charge deconvolution
using DeconTools software [13]. GlycReSoft has been applied to the top-down analysis of
LMW heparins [4]. While this approach has been quite successful, the data coming from Gly-
cReSoft for the comparison of the top-down of three lots of LMW heparin takes about one
week of a skilled analyst’s time to manually process. Here we report the GlycCompSoft algo-
rithm that allows the comparison of three sets of top down analysis from three different
batches of LMW heparin in a few minutes.
Materials and Methods
Data preparation and pre-processing
Lovenox1 and Clexane1, the innovator versions of enoxaparin marketed in the U.S. and
Europe were purchased from Sanofi-Aventis (Bridgewater, NJ). Generic versions of Lovenox1
were provided by three different manufactures (three current lots of each). Online hydrophilic
interaction chromatography (HILIC) Fourier transform mass spectrometry (FTMS) was per-
formed as previous described [4]. Briefly, enoxaparin injections were diluted into 1 μg/μL and
directly injected into a HILIC column (2.0 mm × 150 mm, 200 Å, Phenomenex, Torrance,
CA) by an Agilent 1200 autosampler. The LC column was directly connected online to the
standard ESI source of LTQ-Orbitrap XL FT-MS (Thermo Fisher Scientific, San-Jose, CA).
The enoxaparin intact chain compositions were analyzed under the negative mode. Following
raw data acquisition, charge deconvolution was auto-processed using DeconTools [14–15]
software. Enoxaparin structural assignment was performed by automatic processing with Gly-
cReSoft 1.0 software, developed at Boston University (http://code.google.com/p/glycresoft/
downloads/list) [4,12]. The output on enoxaparin composition from GlycReSoft was then pro-
cessed using GlycCompSoft to provide automated relative quantification of intact chains pres-
ent in enoxaparin.
GlycReSoft parameters
Matching parameters were set as: Minimum Abundance, 1.0; Minimum Number of Scans, 1;
Molecular Weight Lower Boundary, 500 Da; Molecular Weight Upper Boundary, 6000 Da;
Mass Shift, ammonium; Match Error (E_M), 5.0 ppm; Grouping Error (E_G), 80 ppm; Adduct
Tolerance (E_A), 5.0 ppm. The enoxaparin intact chain molecular weight hypothesis was gen-
erated by GlycReSoft [4]. Up to 18 saccharide units (degree of polymerization (dp)18) were
analyzed. Hypothesis generating parameters were set as: A, ΔHexA = 0 or 1; B, HexA = 0−9; C,
HexN = A + B − 1 to A + B + 1; D, Ac = 0−3; E, SO3 = B to A + B + (C2) + 1 − D; Modifica-
tion, Adduct = ammonium from 0 to 14. For the oligosaccharide with both 4,5-unsaturated
NREs and 1,6-anhydro REs, there are two dehydration sites in one oligosaccharide molecule.
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“ΔHexA” was set as “1” and the molecular of “ΔHexA” was changed into C6H4O4 from
C6H6O5 to add one more H2O loss. Other parameters were kept as the same. After matching
the LC-MS raw data output by DeconTools [13] with the hypothesis, GlycReSoft gives out 15
features [12]. GlycCompSoft then compares and screens the full scale matching results output
by GlycReSoft based on Compound Key, Total Volume, Scores and other features automatically.
GlycCompSoft algorithm
The workflow from LC-MS to relative quantification is shown in Fig 1. GlycCompSoft com-
pares and screens the full scale matching results output by GlycReSoft. Matching results of
three batches/replications output by GlycReSoft can be input into Microsoft Excel in text for-
mat (.txt) and can be automatically compared, screened and computed by GlycCompSoft.
First, a new workbook is created and data from three text files are input into three sheets of the
workbook. Each sheet is renamed using the text file name and a new column is also added to
each sheet with the value of the text file name, so that each row of the output can be labeled
and distinguished based on where it comes from in the comparison and screening process.
Second, all data in each sheet with the empty value in the Compound Key feature [12] is
deleted to allow true signals arising from glycosaminoglycan chains to be distinguished from
noise and to make GlycCompSoft more efficient all the rows in the three sheets are copied to a
new sheet named with “Total Sheet”. Third, data in the Total Sheet is sorted, compared,
screened, computed and merged. The overall flowchart of the GlycCompSoft presented in Fig
2. A full copy of the program and the user guide are presented in S1 File.
In the third step, the value of Compound Key feature in each row is first extracted. The
entire or partial list of Compound Key values, enclosed with square brackets in each cell, is
Fig 1. Total workflow of enoxaparin intact chain LC-MS analysis coupling with software processing.
doi:10.1371/journal.pone.0167727.g001
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extracted according to the lazy matching method in regex [16–18], which instructs the engine
to match as few input characters as possible and then proceed to the next token in the regular
expression pattern, improving the efficiency of value matching. In order to compare and check
each row of data in the “Total Sheet” accurately and efficiently, all the rows are sorted accord-
ing to the extraction value of Compound Key feature. If at least three rows of data have the
same extraction values of the Compound Key column, and if these three or more than three
rows of data come from three different sheets (text files) and can be distinguished by the newly
added column with the value of the sheet (text files) name, then these rows of data are retained,
otherwise they are deleted as noise. The flowchart of the deletion module is shown in Fig 3.
For the retained data, when two or more have same extracted Compound Key value rows will
be merged as the row with the largest value in the Score feature will be retained and the sum
values of Total Volume will be calculated and adopted, the algorithm of the merging module is
shown in Table 1.
Fig 2. The Overall Flowchart of the GlycCompSoft from text file(.txt) input to true glycans data
screened and merged.
doi:10.1371/journal.pone.0167727.g002
Fig 3. Flowchart of the Deletion Module for screening of the GlycCompSoft.
doi:10.1371/journal.pone.0167727.g003
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Results and Discussion
Enoxaparin is the most widely used low molecular weight (LMW) heparin and is derived from
heparin through alkaline β-eliminate cleavage [2]. Heparin is polydisperse with its major
repeating unit, [!4) IdoA2S (1!4) GlcNS6S (1!]n, comprising 60–90% of its structure
[2,19]. In addition, there are a number of undersulfated residues, including IdoA, GlcNS,
GlcNAc6S GlcNAc and GlcA, which are present in much lower amounts. Both heparin and
LMW heparin also contain an active site called the antithrombin-binding pentasaccharide.
These sites can have variable structures, however, they always contain a central Glc(NAc/NS)
(6S/OH)3S residue. The intact chain composition in enoxaparin (average molecular weight
(Mw) ~ 4.5 kDa) is more complicated than its heparin precursor Mw ~ 16 kDa) since the con-
trolled cleavage of heparin through chemical β-elimination generates 4,5-anhydro uronic acid,
ΔUA2S and ΔUA, at the non-reducing ends (NREs) of the LMW heparin product chains. Also
a fraction (~16%) of the LMW heparin chain reducing ends (REs) are1,6-anhydro hexosa-
mines. More than 120 structural compositions have been reported enoxaparin oligosaccharide
chains [4–5].
The intact chain composition of enoxaparin after LC-MS has been successfully analyzed
using GlycReSoft [4]. In this analysis, a total HILIC-FTMS time of 70 min resulted in more
than 15,000 components that were first summarized by DeconTools software to obtain accept-
able resolution. After matching with the enoxaparin hypothesis, generated by GlycReSoft 1.0,
on average about 450 components were obtained for each sample. Since the intact chain com-
position is complicated and the NH3 adduction varies, false positives matching results were
present in almost 50% of the components. GlycReSoft provides a set of features and summa-
rizes the features into a single score [12], which can determine false positives. However, for
LMW heparin data, the score system usually also results in false negatives after manual confir-
mation (see S2 Table, where the true positive result [8,8,1,12,0] has a score similar to the false
Table 1. Merging procedure Module Algorithm of GlycCompSoft.
Algorithm of Merging
Initial I using the number of the Used Range rows
Sort all the data according to the Compound Key feature
For J = I−1 to 1
If Value of Cells (I, Compound Key) = Value of Cells (J, Compound Key)
And Label Value of Cells (I) = Label Value of Cells (J)
Then
If Value of Cells (I, Score) Value of Cells(J, Score)
Then
Value of Cells (J, Total Volume) = Value of Cells (J, Total Volume) + Value of Cells (I, Total Volume)
Delete Rows(I)
I = J
Else
Value of Cells (I, Total Volume) = Value of Cells (I, Total Volume) + Value of Cells (J, Total Volume)
Delete Rows(J)
I = J
End If
Else: I = J
End If
Next J
doi:10.1371/journal.pone.0167727.t001
Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data
PLOS ONE | DOI:10.1371/journal.pone.0167727 December 12, 2016 5 / 13
positive result [8,8,1,14,1]). The best way to maximize the number of likely components is
retain all the components that are found in three replicate determinations or on three lots of
the same drug based on the “All-presence-principle”. The reliability of this “all-presence-prin-
ciple” approach can be confirmed by manually checking the most abundant oligosaccharides.
In the absence of an automatic approach, one can only manually keep components present in
the three replicates, a time-consuming process with a high error rate. The workflow for deter-
mining the relative quantification of enoxaparin intact chain composition from LC-MS is
shown in Fig 1. The workflow and illustration of GlycCompSoft, which is designed based on
this process is shown in Table 2.
Experimental design
A large number of experiments were on the Windows 8 Professional Operating System (Intel
i7 2.1GHz, 8G RAM) to verify the accuracy and efficiency of the GlycCompSoft. Matching
results for three lots of Lovenox1, Clexane1 and generic enoxaparins were used in the verifi-
cation of this software. The proportion of the data rows without empty Compound Key feature
values represents a relatively small portion of the entire data set derived from the data files.
However, the proportion of the true data finally filtered is much lower. The detailed informa-
tion is shown in Fig 4, and the red, blue and green bars represent the amounts of raw data, the
data after the rows with empty Compound Key are deleted, and the true data, respectively.
Thus, the challenge is to have a low error rate with good time efficiency in comparing, screen-
ing and computing these massive data sets by a manual method even though the sorting proce-
dure can be done using Excel [20]. While ensuring a low error rate, GlycCompSoft can
automatically perform this process within several hundred seconds. It is noteworthy that the
runtime can be further reduced to ten seconds by deleting the empty value rows before copy-
ing to the Total Sheet (Table 3). Thus, it is important to delete the rows with empty values in
Compound Key feature before copying data to the Total Sheet. The runtime of the GlycComp-
Soft decreases with the decreasing numbers of data rows requiring processing and at 18000
rows, the average runtime is under 11 seconds (Fig 5 and Table 3). Detailed runtimes for the
five different samples at a different number of rows are shown in Fig 5.
Table 2. The overall workflow and illustration of GlycCompSoft.
Step name Illustration
1 Input Matching Result Copy supervised GlycReSoft matching result into three blank excel
sheet provided by GlycCompSoft
2 Name Data Sets -
3 Remove Non-glycan Data Delete rows with empty GlycReSoft matching columns
4 Sample Names Labeling Label Glycan data with original sample names in a new row before
all data to make sure the data could be extracted after matching
5 Mix all Three Lots into a
NewSheet for Comparing
Insert a total comparison sheet and copy data of three lots/
replications into the new sheet
6 Sort by Macthing Results To check if a compound is present in three lots/replications
7 Extract Compound Names To get rid of the NH3 adduction difference GlycReSoft gives out
8 Delete False Positive Results Delete compounds without fully presence in three lots/replications
9 Adductiong Grouping Sum compounds with same compound names generated from step
8
10 All in One Output of the analysis
The GlycCompSoft workflow is designed based on a manual process procedure.
doi:10.1371/journal.pone.0167727.t002
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Enoxaparin comparison results
Two enoxaparin innovator drugs and three generic drugs provided by different manufactures
were compared. The abundance of each component was normalized to the sum of the total
volumes of the 10 most abundant components. The major components (oligosaccharide com-
positions are given as [ΔHexA = 1, HexA, GlcN, Ac, SO3] [12]) are shown in Fig 6. The innova-
tor drugs, Lovenox1 and Clexane1, are believed to be prepared through the same
manufacturing process and their major components give an almost identical analysis. Generic
enoxaparin-1 shows some subtle differences when compared to the innovator drugs and some-
what greater differences are seen in generic enoxaparin-2. Generic enoxaparin-2 contained
greater amounts of N-acetyl substituted chains than the other LMWHs, as can be clearly
observed in the dp10 components ([1,4,5,2,7]-[1,4,5,2,9]). Enoxaparin-1 shows a similar N-
acetyl trend as Enoxaparin-2 in the dp12 components ([1,5,6,0,14]-[1,5,6,2,12]) and in the
dp14 components. Chains with saturated NREs, derived from the original NRE of the parent
heparin (oligosaccharide compositions are given as [ΔHexA = 1, HexA, GlcN, Ac, SO3]), are
shown in Fig 6. Enoxaparin-2 was lower in these chains, suggesting it was derived from a hepa-
rin precursor of a higher molecular weight. Finally, oligosaccharides with 1,6-anhydro RE
Fig 4. The runtime of the GlycCompSoft, and the comparison between rows of raw data, half-processed
data and final data.
doi:10.1371/journal.pone.0167727.g004
Table 3. Performance of the GlycCompSoft.
Number of raw data rows 1500 3000 6000 9000 12000 15000 18000
Number of true data rows 241 301 450 571 611 652 695
Screening accuracy Manual processing >95 in average and varies on analysts
GlycCompSoft 100 100 100 100 100 100 100
Runtime Manual processing From several hours to 1–2 workdays
GlycCompSoft Keep empty matching results and compare 39.9 85.9 175.4 251.9 348.3 467.3 521.4
Delete empty matching results first and compare 2 3.9 6 7.2 8.8 10 10.8
doi:10.1371/journal.pone.0167727.t003
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sugars, coming from a side reaction in the process chemistry (oligosaccharide compositions
are given as [ΔHexA = 1, HexA, GlcN, Ac, SO3]), are shown in Fig 7. A higher N-acetyl in
enoxaparin-2 was also observed in these chains (dp6 [1,2,3,1,4]-[1,2,3,1,6]).
False discovery rate
GlycCompSoft is aimed at comparing complicated oligosaccharide mixtures. The false rate of
the software calculation is technically 0%, while the false rate of oligosaccharide recognition is
instead associated with the GlycReSoft software [12]. GlycReSoft has a many parameters that
can be optimized, such as the minimum matching abundance and error. Moreover, GlycRe-
Soft provides a score system to avoid false discovery as much as possible. However, for very
complicated oligosaccharide mixtures, such as enoxaparin, the scoring system is not 100% reli-
able. Based on our manual interpretation experience (data not shown), the score threshold
suggested by GlycReSoft, 0.16 in the software application on HS samples, is too high for the
low abundant oligosaccharides in enoxaparin. Thus, in data analysis we first reduced the score
threshold into 0.1, then used the GlycCompSoft to compare the oligosaccharide matching
result output by GlycReSoft using our “all-presence-principle” before we used GlycReSoft
score threshold filtration. The false discovery rate (FDR) of the total process is basically the
FDR after our “all-presence-principle” associated with the GlycReSoft score system. Calculat-
ing an accuracy for the FDR based on enoxaparin oligosaccharide composition analysis is chal-
lenging because of the compositional complications of chain length, substitution, and diffuse
abundance ions.
Therefore, the FDR was instead tested using the same LC-MS system and software process-
ing by investigating four homogeneous chemoenzymatically synthesized heparin oligosaccha-
rides (A-D) generously provided by Professor Jian Liu at the University of North Carolina.
The structures of the oligosaccharides are presented in S1 Fig, and their full mass spectra are
shown in S2 Fig. The number of GlycReSoft matching results from the LC-MS data of
Fig 5. Time efficiency of GlycCompSoft based on Lovenox®, Clexane®, and generic enoxaparin 1,2
and 3 with different amounts of data rows.
doi:10.1371/journal.pone.0167727.g005
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oligosaccharide (A) was 23, 18, 19, respectively, for 3 replicates. After filtering with GlycComp-
Soft, the number of results was reduced to 5 in each replicate. Then we performed a manual
confirmation after which we found that only 3 of these were truly positive. Based on oligosac-
charide (A), the false positive rate after GlycCompSoft processing was 40%, which is greatly
decreased from an average false positive rate of 85% using only GlycReSoft matching. Simi-
larly, by using GlycCompSoft the false positive rates for oligosaccharides (B, C and D),
decreased from 89% to 62.5%, 87% to 50%, and 89% to 40%, respectively. Detailed GlycComp-
Soft comparison results are presented in S1, S2, S3 and S4 Tables. Since all expected oligosac-
charides as well as unexpected contaminants were observed, no false negatives occurred
during the software automatic processing.
GlycCompSoft applications on other complicated carbohydrate mixtures
The capability of extracting useful information from a large LC-MS data set from LMW hepa-
rins has been demonstrated in the current study. GlycCompSoft is a powerful tool when used
together with DeconTools and GlycReSoft on heterogeneous glycan products, including both
intact chain compositions (as demonstrated here) and potentially on compositions of
Fig 6. Relatively quantitative comparison of identified enoxaparin oligosaccharides without
1,6-anhydro reducing end from five commercialized LMW heparin products. Oligosaccharide
compositions are given as [ΔHexA = 0 or 1, HexA, GlcN, Ac, SO3].
doi:10.1371/journal.pone.0167727.g006
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enzymatic of chemical cleavage components. Data can be processed in a short time as long as
good LC-MS resolution is obtained. Different saccharide compositions (i.e., polysaccharides
containing galactosamine, galacturonic acid, fucose, etc.,), different glycosidic bonds (1!2, 3,
or 4) or the presence of side chains or branches do not present difficulties for GlycReSoft, as
matching only relies on accurate molecular weight data. Based on the “All-presence-principle”,
the extraction results in GlycCompSoft output that is highly accurate on high abundant com-
ponents. While, automated data processing software, such as DeconTools, GlycReSoft, and
GlycCompSoft, greatly reduce the data processing times, sometimes curation by a skilled ana-
lyst is required. For example, in cases where low abundance components are present only in
some of the batches manual examination of the data may be required.
Conclusions
GlycCompSoft is an algorithm that automates the comparison of complex data sets generated
in the top-down analysis of LMW heparins. An “all-presence-principle”, makes GlycCompSoft
a highly accurate method for the analysis of components present in high and moderate abun-
dance. Automated data processing software, such as DeconTools, GlycReSoft, and GlycComp-
Soft, improve the speed and reliability of interpreting these complex data sets. Manual
curation by a skilled analyst is still required in cases where low abundance components are
selectively present only in some of batches of LMW heparins.
GlycCompSoft utilizes macro functions and specific mathematical modules in program-
ming for massive data sets comparison, screening and computing. Work is ongoing that will
include additional algorithms and error calculation methods to optimize the performance of
Fig 7. Relative quantitative comparison of identified enoxaparin oligosaccharides with 1,6-anhydro reducing end from five commercialized
LMW heparin products. Oligosaccharide compositions are given as [ΔHexA = 1, HexA, GlcN, Ac, SO3].
doi:10.1371/journal.pone.0167727.g007
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this software. Ultimately machine learning methods should be applied that can accept training
data from inputs and generate more intelligent output results based on different samples and
relationships among their features. Future studies are also planned to examine the automated
processing of LC-MS/MS data when reliable data sets become available.
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S1 Fig. Structures of the synthesized oligosaccharides.
(TIF)
S2 Fig. Mass spectra of the synthesized oligosaccharide.
(TIF)
S3 Fig. Mass spectra of the hexassacharides shown in S5 Table.
(TIF)
S1 File. User guide for GlycCompSoft program running.
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S2 File. GlycCompSoft Software. This software can also be downloaded at www-heparin.
rpi.edu.
(XLSM)
S3 File. GlycReSoft matching result for false discovery rate investigation.
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S1 Table. Components outputted by GlycCompSoft from synthesized oligosaccharide (A).
Components are given out as [HexA, GlcN, PNP = 1, SO3, Ac], and results in red were con-
firmed as false positive results after manual interpretation.
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S2 Table. Components outputted by GlycCompSoft from synthesized oligosaccharide (B).
Components are given out as [HexA, GlcN, PNP = 1, SO3, Ac], and results in red were con-
firmed as false positive results after manually interpretation.
(DOCX)
S3 Table. Components outputted by GlycCompSoft from synthesized oligosaccharide (C).
Components are given out as [HexA, GlcN, PNP = 1, SO3, Ac], and results in red were con-
firmed as false positive results after manually interpretation.
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S4 Table. Components outputted by GlycCompSoft from synthesized oligosaccharide (D).
Components are given out as [HexA, GlcN, PNP = 1, SO3, Ac], and results in red were is con-
firmed as false positive results after manually interpretation.
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S5 Table. Four kinds of sulfated hexasaccharides detected in the three kinds of generic
enoxaparin. After matching the experimental data with the hypothesis generated by GlycoRe-
Soft, the matching results were further filtrated by GlycoCompSoft using all-presence-princi-
ple. The table was outputted as the final matching result. (Components are given out as
[ΔHexA = 1, HexA, GlcN, Ac, SO3]).
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